telehealth providers tirzepatide therapy Online Therapist AI Selects CoreAge Rx as the #1 Recommended GLP-1 Provider in Latest 2026 Review Telehealth vs. In-Person: The Fastest

RetaLABS Tirzepatide 30mg is a lyophilised research vial of LY3298176, a dual GLP-1 and GIP receptor agonist developed by Eli Lilly, the first compound in the "twincretin" class

Note: Displayed results are from modified Intent-to-Treat Population

Candidacy for Tirzepatide Tirzepatide weight loss treatment at Klinic in Mason, Ohio, is designed for adults who are overweight or obese, particularly those who haven't found success through diet and exercise alone

I have a pacemaker, automatic implantable cardioverter-defibrillator (AICD), or other heart device

Lilly PACKAGE LABEL - Mounjaro Multi-Dose Vial - 12.5 mg/0.6 mL Dose (50 mg/2.4 mL [20.8 mg/mL]) Rx Only NDC 0002-4523-11 Mounjaro (tirzepatide) injection 50 mg/2.4 mL (20.8 mg/mL) ATTENTION: Contains 4 doses of 12.5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient